WELSH AMY (Chief Commercial Officer) reported 2 transactions at AGILE THERAPEUTICS INC
Review the transaction codes below to understand the nature of each event.
Filed: 8/26/2024ACC: 0001104659-24-092943
Officer· Chief Commercial Officer
Since Nov 2022
-13.50K
Net shares
Net seller
$20.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
13.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−10.13K
Price / share
$1.52
Trade value
$15.39K
% of position
75.0%
8/26/2024
13.50K→3.38K
Common Stock
Direct
Shares
−3.38K
Price / share
$1.52
Trade value
$5.13K
% of position
New position
8/26/2024
3.38K→0.00
Total
Net shares
−13.50K
Net value
-$20.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/26/2024 | D · Disposition | −10.13K | $1.52 | $15.39K | 75.0% | 13.50K | 3.38K |
| Common Stock Direct | 8/26/2024 | D · Disposition | −3.38K | $1.52 | $5.13K | New position | 3.38K | 0.00 |
| Total | −13.50K | -$20.52K | ||||||
Derivative Transactions0
No derivative transactions reported